University Hospital Zurich
Zurich, 8091, Switzerland
Location status: Recruiting
NCT Number: NCT06579547
The goal of this clinical trial is to determine how effectively bone structures of the human skeleton can be visualized using Deep Learning (DL) augmented Magnetic Resonance Imaging (MRI) in individuals with inflammatory and degenerative joint changes, compared to Computed Tomography (CT). MRI is a technique that operates without the use of X-rays. The main question it aims to answer is:
1. Can DL MRI accurately depict bone structures as well as CT? 2. Can DL MRI be used as an alternative to CT to avoid exposure to X-rays in the future?
Researchers will compare DL MRI scans to CT scans to see if DL MRI can effectively replace CT in visualizing bone structures without the use of radiation.
Participants will:
1. Undergo MRI scans of their skeletal system that will then be processed using DL. 2. Undergo CT scans of the same body region for comparison purposes.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Zurich, 8091, Switzerland
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo MRI scans of their skeletal system, followed by the Intervention of a Low Dose CT scan of the same body region for comparison purposes.
Time frame: one day (day of MRI and CT examination)
Each bone is scored separately. The scale is 0-10, based on the proportion of eroded bone compared to the "assessed bone volume," judged on all available images: 0: no erosion; 1: 1-10% of bone eroded; 2: 11-20%, etc. For long bones, the "assessed bone volume" is from the articular surface (or its best estimated position if absent) to a depth of 1 cm, while in carpal/tarsal bones it is the whole bone.
Example of bone list for hands: carpal bones, distal radius, distal ulna, metacarpal bases; metacarpophalangeal, MCP, joints: metacarpal head, phalangeal base; maximum points: 230.
A higher score means more bone erosions.
Note: The total score will vary according to body area imaged, this will be taken into account in the final analysis.
Time frame: one day (day of MRI and CT examination)
0: no narrowing, 1: focal or mild (< 33%), 2: moderate (34-66%), 3: moderate to severe (67-99%), 4: ankylosis
A higher score means more joint space narrowing.
Note: The total score will vary according to body area imaged, this will be taken into account in the final analysis.
Time frame: one day (day of MRI and CT examination)
Scale from 1 to 4
A higher score means better image quality.
Time frame: one day (day of MRI and CT examination)
Scale from 1 to 4
A higher score means better image quality.
Time frame: one day (day of MRI and CT examination)
Scale from 1 to 4
A higher score means better image quality.
Time frame: one day (day of MRI and CT examination)
Average signal of erosion minus average signal of adjacent healthy bone, divided by the average background signal
A higher score means better contrast of erosions when standardized for healthy adjacent bone and against the background.
Time frame: one day (day of MRI and CT examination)
Average signal of erosion divided by the average background signal
A higher score means better contrast of erosions against the background.
Contact information is provided by the study sponsor or research team.
Carina Obermüller, Dr. med.
CONTACT
0041763654453
Roman Guggenberger, PD Prof. Dr. med.
CONTACT
Roman Guggenberger
Other
Single-center Prospective Comparison of Diagnostic Performance of Deep-learning Agumented UTE/ZTE MRI Sequences and Standard-of-care Low Dose CT for Rheumatologic Patients With Musculoskeletal Disease
Acronym: DLZTECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04580225
Arthritis, Joint Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06550024
Arthritis, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT02717559
Anterior Cruciate Ligament Injuries, Arthritis
View Trial DetailsNCT07349264
Arthritis, Joint
Cheras, Kuala Lumpur, Malaysia
View Trial Details